Physician profile
Smitha Kumar
NPI 1619965688
$1,915.49
in general payments reported to CMS, 2019-2025
20 companies · $16.54 in 2025
The $16.54 reported for 2025 was less than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,326 · 2020: $172 · 2021: $125 · 2022: $94.69 · 2023: $88.93 · 2024: $92.52 · 2025: $16.54.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $198.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $197.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $294.16 | 2019-2024 | Arexvy, Trelegy Ellipta |
| Janssen Pharmaceuticals, INC | $244.36 | 2019-2024 | Spravato |
| Amgen INC. | $170.73 | 2019-2020 | |
| Novo Nordisk INC | $151.95 | 2019-2024 | Ozempic |
| Boehringer Ingelheim Pharmaceuticals, INC. | $147.20 | 2019-2020 | |
| Astrazeneca Pharmaceuticals Lp | $115.35 | 2019-2020 | |
| Merck Sharp & Dohme LLC | $113.85 | 2019 | |
| Mylan Specialty L.P. | $101.71 | 2019 | |
| Astellas Pharma US INC | $99.99 | 2021 | |
| Pfizer INC. | $98.85 | 2019-2020 | |
| Lilly USA, LLC | $89.26 | 2019-2022 | |
| Abbott Laboratories | $60.85 | 2022 | |
| Arbor Pharmaceuticals, INC. | $53.73 | 2019 | |
| Teva Pharmaceuticals USA, INC. | $42.12 | 2019 | |
| Sanofi-Aventis U.S. LLC | $31.18 | 2019 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $28.72 | 2019 | |
| Avanir Pharmaceuticals, INC. | $24.13 | 2019 | |
| Takeda Pharmaceuticals U.S.A., INC. | $17.77 | 2019 | |
| Exact Sciences Corporation | $16.54 | 2025 | Cologuard Collection Kit |
| Sanofi Pasteur INC. | $13.04 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Smitha Kumar listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.